Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Haemonetics Corporation (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Their technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. Haemonetics' solutions aim to improve the quality, safety, and availability of blood and plasma products, optimize patient blood management, and enhance the efficiency of healthcare delivery.
The Boston headquarters serves as the central hub for Haemonetics' global strategy, corporate management, research and development leadership, and key administrative functions.
Located in a modern office building in Boston's financial district, offering employees access to city amenities and a dynamic business environment. The space is designed to foster collaboration and innovation.
Haemonetics promotes a work culture focused on innovation, patient impact, collaboration, and integrity. Employees are encouraged to contribute to the company's mission of improving healthcare worldwide.
Its location in Boston provides strategic advantages, including proximity to leading research institutions, a rich talent pool in biotechnology and healthcare, and a strong network of industry partners.
Haemonetics operates globally with a presence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Their functions supported globally include manufacturing, research & development, sales and marketing, customer service and technical support, and distribution networks to serve hospitals, blood collection centers, and plasma donation centers worldwide.
125 Summer Street
Boston
MA
USA
Address: 400 Wood Road, Braintree, MA 02184, USA
Supports North American operations with manufacturing, R&D, and customer support for various product lines.
Address: 1000 HemaDrive, Union, SC 29379, USA
Major production hub for North America and global distribution, focusing on high-volume manufacturing.
Address: Signy Centre, En Fléchère, Route de Divonne 48, CH-1260 Nyon, Switzerland
Coordinates sales, marketing, and distribution activities across the EMEA region, tailoring solutions to local healthcare needs.
Address: Plot 120 & 122, Bayan Lepas Industrial Estate, Phase IV, 11900 Penang, Malaysia
Key manufacturing site for various Haemonetics products, enhancing supply chain efficiency for Asia-Pacific and other global markets.
Address: Parque Industrial Pacifico, Tijuana, Baja California, Mexico
Supports North American and global supply chains with cost-effective manufacturing capabilities.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Haemonetics' leadership includes:
Haemonetics has been backed by several prominent investors over the years, including:
Haemonetics has seen some key appointments and transitions in its executive team and board over the past year, reflecting strategic shifts and growth initiatives.
Discover the tools Haemonetics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Haemonetics commonly uses the first initial followed by the last name for its email addresses. Variations might exist, but this is a frequently observed pattern.
[first_initial][last]@haemonetics.com
Format
jsmith@haemonetics.com
Example
85%
Success rate
Haemonetics Corporation • May 7, 2024
Haemonetics announced its financial results for the fourth quarter and full fiscal year ended March 30, 2024. The company highlighted revenue growth driven by its Plasma and Hospital businesses....more
Haemonetics Corporation • February 6, 2024
Haemonetics reported strong financial results for the third quarter of fiscal year 2024, with notable performance in its Plasma franchise and continued growth in its Hospital business....more
Haemonetics Corporation • January 8, 2024
Haemonetics announced its participation in the Leipzig Interventional Course (LINC) 2024, where it planned to showcase its VASCADE Vascular Closure System and ClotChip hemostasis testing system....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Haemonetics, are just a search away.